Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SHS
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
20,169,972
-
Shares change
-
+1,077,468
-
Total reported value, excl. options
-
$139,370,146
-
Value change
-
+$7,129,511
-
Number of buys
-
22
-
Number of sells
-
-31
-
Price
-
$6.91
Significant Holders of AC Immune SA - SHS (ACIU) as of Q1 2020
60 filings reported holding ACIU - AC Immune SA - SHS as of Q1 2020.
AC Immune SA - SHS (ACIU) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,169,972 shares
.
Largest 10 shareholders include BVF INC/IL (11,342,505 shares), Temasek Holdings (Private) Ltd (2,614,095 shares), Prosight Management, LP (1,058,697 shares), Artal Group S.A. (1,000,000 shares), ACADIAN ASSET MANAGEMENT LLC (747,781 shares), RENAISSANCE TECHNOLOGIES LLC (677,311 shares), BlackRock Inc. (591,030 shares), MILLENNIUM MANAGEMENT LLC (525,679 shares), WELLS FARGO & COMPANY/MN (209,540 shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (201,319 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.